Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

Danilova, Ludmila, Anagnostou, Valsamo, Caushi, Justina X., Sidhom, John-William, Guo, Haidan, Chan, Hok Yee, Suri, Prerna, Tam, Ada, Zhang, Jiajia, Asmar, Margueritta El, Marrone, Kristen A., Naidoo, Jarushka, Brahmer, Julie R., Forde, Patrick M., Baras, Alexander S., Cope, Leslie, Velculescu, Victor E., Pardoll, Drew M., Housseau, Franck, Smith, Kellie N. · 2018 · Cancer Immunology Research

Published version of a preprint

Abstract

Mutation-associated neoantigens (MANA) are a target of antitumor T-cell immunity. Sensitive, simple, and standardized assays are needed to assess the repertoire of functional MANA-specific T cells in oncology. Assays analyzing in vitro cytokine production such as ELISpot and intracellular cytokine staining have been useful but have limited sensitivity in assessing tumor-specific T-cell responses and do not analyze antigen-specific T-cell repertoires. The FEST (Functional Expansion of Specific T cells) assay described herein integrates T-cell receptor sequencing of short-term, peptide-stimulated cultures with a bioinformatic platform to identify antigen-specific clonotypic amplifications. This assay can be adapted for all types of antigens, including MANAs via tumor exome-guided prediction of MANAs. Following in vitro identification by the MANAFEST assay, the MANA-specific CDR3 sequence can be used as a molecular barcode to detect and monitor the dynamics of these clonotypes in blood, tumor, and normal tissue of patients receiving immunotherapy. MANAFEST is compatible with high-throughput routine clinical and lab practices. Cancer Immunol Res; 6(8); 888–99. ©2018 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2326-6066.cir-18-0129

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 42

  1. Lu, 2016, Targeting neoantigens for cancer immunotherapy, Int Immunol, 28, 365, 10.1093/intimm/dxw026 · DOI
  2. Yee, 2002, Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses, Nat Rev Cancer, 2, 409, 10.1038/nrc820 · DOI
  3. Moodie, 2010, Response definition criteria for ELISPOT assays revisited, Cancer Immunol Immunother, 59, 1489, 10.1007/s00262-010-0875-4 · DOI · Paper page
  4. Craig, 2008, Flow cytometric immunophenotyping for hematologic neoplasms, Blood, 111, 3941, 10.1182/blood-2007-11-120535 · DOI · Paper page
  5. Meyer, 2000, Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers, Proc Natl Acad Sci USA, 97, 11433, 10.1073/pnas.190335897 · DOI
  6. Barnes, 2004, Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells, Eur J Immunol, 34, 1570, 10.1002/eji.200424898 · DOI
  7. Tran, 2015, Immunogenicity of somatic mutations in human gastrointestinal cancers, Science, 350, 1387, 10.1126/science.aad1253 · DOI · Paper page
  8. Lu, 2014, Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions, Clin Cancer Res, 20, 3401, 10.1158/1078-0432.CCR-14-0433 · DOI · Paper page
  9. Andersen, 2012, Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers, Nat Protoc, 7, 891, 10.1038/nprot.2012.037 · DOI
  10. Iezzi, 1998, The duration of antigenic stimulation determines the fate of naive and effector T cells, Immunity, 8, 89, 10.1016/S1074-7613(00)80461-6 · DOI · Paper page
  11. Wells, 1997, Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response, J Clin Invest, 100, 3173, 10.1172/JCI119873 · DOI · Paper page
  12. Sun, 1999, Antigen-specific T cell activation and proliferation during oral tolerance induction, J Immunol, 162, 5868, 10.4049/jimmunol.162.10.5868 · DOI
  13. Carlson, 2013, Using synthetic templates to design an unbiased multiplex PCR assay, Nat Commun, 4, 2680, 10.1038/ncomms3680 · DOI · Paper page
  14. Robins, 2009, Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells, Blood, 114, 4099, 10.1182/blood-2009-04-217604 · DOI · Paper page
  15. Anagnostou, 2017, Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer, Cancer Discov, 7, 264, 10.1158/2159-8290.CD-16-0828 · DOI · Paper page
  16. Jones, 2015, Personalized genomic analyses for cancer mutation discovery and interpretation, Sci Transl Med, 7, 283ra53, 10.1126/scitranslmed.aaa7161 · DOI · Paper page
  17. Sausen, 2013, Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma, Nature genetics, 45, 12, 10.1038/ng.2493 · DOI · Paper page
  18. Szolek, 2014, OptiType: precision HLA typing from next-generation sequencing data, Bioinformatics, 30, 3310, 10.1093/bioinformatics/btu548 · DOI · Paper page
  19. Nielsen, 2016, NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets, Genome Med, 8, 33, 10.1186/s13073-016-0288-x · DOI · Paper page
  20. Lundegaard, 2008, NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11, Nucleic Acids Res, 36, W509, 10.1093/nar/gkn202 · DOI · Paper page
  21. Lundegaard, 2008, Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers, Bioinformatics, 24, 1397, 10.1093/bioinformatics/btn128 · DOI · Paper page
  22. Stranzl, 2010, NetCTLpan: pan-specific MHC class I pathway epitope predictions, Immunogenetics, 62, 357, 10.1007/s00251-010-0441-4 · DOI · Paper page
  23. Kim, 2009, Derivation of an amino acid similarity matrix for peptide: MHC binding and its application as a Bayesian prior, BMC Bioinformatics, 10, 394, 10.1186/1471-2105-10-394 · DOI · Paper page
  24. Team, 2014, R: A language and environment for statistical computing
  25. Gentleman, 2004, Bioconductor: open software development for computational biology and bioinformatics, Genome Biol, 5, R80, 10.1186/gb-2004-5-10-r80 · DOI · Paper page
  26. Benjamini, 1995, Controlling the false discovery rate - a practical and powerful approach to multiple testing, J Roy Stat Soc B Met, 57, 289, 10.1111/j.2517-6161.1995.tb02031.x · DOI · Paper page
  27. Chang, 2017, shiny: Web Application Framework for R. R package version 1.0.0
  28. Price, 2009, Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection, J Exp Med, 206, 923, 10.1084/jem.20081127 · DOI
  29. Valkenburg, 2016, Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses, Proc Natl Acad Sci USA, 113, 4440, 10.1073/pnas.1603106113 · DOI
  30. Du, 2016, HIV-1-Specific CD8 T cells exhibit limited cross-reactivity during acute infection, J Immunol, 196, 3276, 10.4049/jimmunol.1502411 · DOI
  31. Kloverpris, 2015, CD8+ TCR bias and immunodominance in HIV-1 infection, J Immunol, 194, 5329, 10.4049/jimmunol.1400854 · DOI
  32. Hill, 2014, Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations, J Immunol, 193, 5626, 10.4049/jimmunol.1401017 · DOI
  33. Sidney, 2001, Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules, Hum Immunol, 62, 1200, 10.1016/S0198-8859(01)00319-6 · DOI
  34. Rammensee, 1993, Peptides naturally presented by MHC class I molecules, Annu Rev Immunol, 11, 213, 10.1146/annurev.iy.11.040193.001241 · DOI · Paper page
  35. Motozono, 2014, Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01, J Immunol, 192, 3428, 10.4049/jimmunol.1302667 · doi:10.4049/jimmunol.1302667
  36. Wu, 2011, Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals, Proc Natl Acad Sci USA, 108, 9178, 10.1073/pnas.1105624108 · DOI
  37. Steven, 1997, Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response, J Exp Med, 185, 1605, 10.1084/jem.185.9.1605 · DOI · Paper page
  38. Betts, 2006, HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, 107, 4781, 10.1182/blood-2005-12-4818 · DOI · Paper page
  39. Kirsch, 2015, T-cell receptor profiling in cancer, Mol Oncol, 9, 2063, 10.1016/j.molonc.2015.09.003 · DOI
  40. Pasetto, 2016, Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor, Cancer Immunol Res, 4, 734, 10.1158/2326-6066.CIR-16-0001 · DOI · Paper page
  41. Sidhom, 2017, ImmunoMap: a bioinformatics tool for T-cell repertoire analysis, Cancer Immunol Res, 6, 151, 10.1158/2326-6066.CIR-17-0114 · DOI
  42. Faham, 2017, Discovery of T-cell receptor beta motifs specific to HLA-B27(+) ankylosing spondylitis by deep repertoire sequence analysis, Arthritis Rheumatol, 69, 774, 10.1002/art.40028 · DOI

Cited by

See all 168

Metadata

Authors
Danilova, L., Anagnostou, V., Caushi, J. X., Sidhom, J.-W., Guo, H., Chan, H. Y., Suri, P., Tam, A., Zhang, J., Asmar, M. E., Marrone, K. A., Naidoo, J., Brahmer, J. R., Forde, P. M., Baras, A. S., Cope, L., Velculescu, V. E., Pardoll, D. M., Housseau, F., & Smith, K. N.
Affiliations
1The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Venue
Cancer Immunology Research
Published
2018-07-31
Volume
6
Issue
8
Pages
888-899
ISSN
  • 2326-6066
  • 2326-6074
Cited by
168
References
8
Language
en
Funders
  • NIH (R01 CA203891-01A1)
  • National Institutes of Health (CA121113, CA180950)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity. https://app.cochat.ai/papers/10.1158/2326-6066.cir-18-0129
The paper
Danilova, L., Anagnostou, V., Caushi, J. X., Sidhom, J.-W., Guo, H., Chan, H. Y., Suri, P., Tam, A., Zhang, J., Asmar, M. E., Marrone, K. A., Naidoo, J., Brahmer, J. R., Forde, P. M., Baras, A. S., Cope, L., Velculescu, V. E., Pardoll, D. M., Housseau, F., & Smith, K. N. (2018). The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-18-0129

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.